ReviewCureus2025
Overview and Regional Context of Alzheimer's Disease in the Middle East and North Africa Region.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Translational potential of medicinal plants for Alzheimer's disease: integrated evidence from molecular mechanisms to preclinical and clinical findings.Natural products and bioprospecting · 2026Review
- Plant-mediated green nanoparticles: combining nanometal and biometabolite potential for Alzheimer's treatment.Biomedical engineering online · 2026Review
- Dementia care in the United Arab Emirates: an environmental scan of services, policy, workforce, and caregiving contexts.BMC health services research · 2026Article
- Biopsychosocial risk factors for Alzheimer's disease and related dementias in UK immigrants from the Middle East and North Africa (MENA).medRxiv : the preprint server for health sciences · 2026Article
- The aging gut-glia-immune axis in alzheimer's disease: microbiome-derived mediators of neuroinflammation and therapeutic innovation.GeroScience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) poses a significant global health challenge, particularly in the Middle East and North Africa (MENA) due to unique socio-economic, cultural, and environmental factors. While AD is prevalent worldwide, MENA faces distinct challenges such as rapid urbanization, aging populations, and healthcare disparities, which exacerbate the disease's impact. Both non-modifiable factors like genetics and modifiable factors, including lifestyle and environmental exposures influence AD's prevalence and severity across the region. The economic burden of AD significantly impacts family and societal structures. The need for enhanced research, early diagnosis, culturally tailored healthcare interventions, and robust public health policies to manage and mitigate AD in MENA is apparent. Applying lessons from international contexts to the MENA region and advocating for a multi-faceted approach that integrates medical, social, and policy efforts should help combat this growing health crisis effectively. This comprehensive review assesses the epidemiology, risk factors, and barriers to optimal care for AD across the MENA region, revealing a critical need for region-specific public health strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.